Shandong Wohua Pharmaceutical Co., Ltd. (002107) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Wohua Pharmaceutical Co., Ltd.

Why is Shandong Wohua Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -3.06% and Operating profit at -16.94% over the last 5 years

Flat results in Jun 25

INTEREST(HY) At CNY 0.04 MM has Grown at 540.8%
OPERATING CASH FLOW(Y) Lowest at CNY 112.21 MM
INTEREST COVERAGE RATIO(Q) Lowest at 152,513.8

With ROE of 8.80%, it has a fair valuation with a 4.71 Price to Book Value

Over the past year, while the stock has generated a return of 24.41%, its profits have risen by 144.8% ; the PEG ratio of the company is 0.4

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Wohua Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Wohua Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shandong Wohua Pharmaceutical Co., Ltd.

35.16%

1.26

43.25%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.06%

EBIT Growth (5y)

-16.94%

EBIT to Interest (avg)

56.40

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

1.13

Tax Ratio

18.74%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

24.88%

ROE (avg)

12.98%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.71

EV to EBIT

45.60

EV to EBITDA

31.04

EV to Capital Employed

9.78

EV to Sales

3.93

PEG Ratio

0.37

Dividend Yield

1.98%

ROCE (Latest)

21.44%

ROE (Latest)

8.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 317.46%

RAW MATERIAL COST(Y)

Fallen by -6.52% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -57.66 %

INVENTORY TURNOVER RATIO(HY)

Highest at 1.86%

DEBTORS TURNOVER RATIO(HY)

Highest at 9.15%

DIVIDEND PER SHARE(HY)

Highest at CNY 9.15

NET PROFIT(Q)

At CNY 21.82 MM has Grown at 75.95%

-13What is not working for the Company

INTEREST(HY)

At CNY 0.04 MM has Grown at 540.8%

OPERATING CASH FLOW(Y)

Lowest at CNY 112.21 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 152,513.8

Here's what is working for Shandong Wohua Pharmaceutical Co., Ltd.

Net Profit

At CNY 21.82 MM has Grown at 75.95%

over average net sales of the previous four periods of CNY 12.4 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at -57.66 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 1.86%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 9.15%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share

Highest at CNY 9.15

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 317.46%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -6.52% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Wohua Pharmaceutical Co., Ltd.

Interest

At CNY 0.04 MM has Grown at 540.8%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 112.21 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Lowest at 152,513.8

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest